Argenx Shares Rise on Primary Endpoint Success, Outpacing Market MomentumArgenx SE stock hits €778.40, up 0.8% after a primary endpoint win; market cap €53.8bn and 200‑day SMA at €739.88 signals steady upside.ARGENX SENetherlands Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Jake Connors 23/10/2026, 18:26 3 minutes to read
